Skip to main content
. 2012 Feb 8;67(5):1217–1223. doi: 10.1093/jac/dkr596

Table 2.

Comparison of pharmacokinetic parameters of artemether, dihydroartemisinin and lumefantrine

Parameter Artemether/lumefantrine(N = 13), median (range) Artemether/lumefantrine plus lopinavir/ritonavir(N = 16), median (range) P value
Artemether
Cmax (ng/mL) 112 (20–362) 56 (17–236) 0.03
Tmax (h) 1 (1–4) 2 (1–4) 0.38
 CL/F (L/h) 295 (69–817) 492 (129–1805) <0.01
 V/F (L) 1072 (593–2651) 1487 (762–3485) 0.02
t1/2 (h) 2 (1–5) 1 (1–6) 0.04
 AUC0-last (ng · h/mL) 264 (92–1129) 151 (38–606) <0.01
 AUC0-∞ (ng · h/mL) 271 (97–1150) 162 (44–618) <0.01
Dihydroartemisinin
Cmax (ng/mL) 66 (10–111) 73 (31–224) 0.55
Tmax (h) 2 (1–4) 2 (1–4) 0.89
 CL/F (L/h) 350 (210–942) 424 (280–626) 0.23
 V/F (L) 922 (498–4779) 876 (734–1315) 1
t1/2 (h) 1 (1–3) 1 (1–2) 0.06
 AUC0-last (ng · h/mL) 213 (68–343) 175 (118–262) 0.27
 AUC0-∞ (ng · h/mL) 217 (81–363) 180 (121–272) 0.23
Lumefantrine
Tlag (h) 1 (0–4) 1 (0–1) 0.16
Cmax (ng/mL) 2532 (1071–5957) 7097 (2396–9462) <0.01
Tmax (h) 8 (3–12) 8 (4–12) 0.26
 CL/F (L/h) 10 (3–32) 1 (1–5) <0.01
 V/F (L) 179 (53–860) 86 (59–219) 0.01
t1/2 (h) 23 (6–51) 31 (24–43) <0.01
 AUC0-last (ng · h/mL) 41 119 (12 850–125 200) 199 678 (71 205–251 015) <0.01
 AUC0-∞ (ng · h/mL) 46 925 (14 559–136 297) 267 386 (84 845–344 468) <0.01